ArticleThe Journal of experimental medicine2024

PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.

Jonathan J Hodgins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.